Iowa Administrative Code › Agency 657 - Pharmacy Board › Chapter 39 - Expanded Practice Standards › Rule 657-39.13 - Collaborative Pharmacy Practice

Current through Register Vol. 47, No. 3, July 24, 2024
(1)
Definitions.
For the
			 purpose of this rule, the following definitions shall apply:
"Collaborative pharmacy practice"
means a
				practice of pharmacy whereby one or more pharmacists provides patient care and
				drug therapy management services not otherwise permitted to be performed by a
				pharmacist to patients under a collaborative pharmacy practice agreement with
				one or more practitioners which defines the nature, scope, conditions, and
				limitations of the patient care and drug therapy management services to be
				provided by the pharmacist(s) in order to ensure that a patient achieves the
				desired outcomes.
"Practitioner"
means a physician, dentist,
				podiatric physician, veterinarian, optometrist, or advanced registered nurse
				practitioner who holds an active license to practice in Iowa.
(2)
Collaborative practice
			 agreement.
a. Pursuant to these
			 rules, a pharmacist or pharmacy may engage in collaborative pharmacy practice
			 under a collaborative pharmacy practice agreement with one or more
			 practitioners, or as established by a health system pharmacy and therapeutics
			 committee, to provide patient care and drug therapy management services to one
			 or more patients.
b. A
			 collaborative pharmacy practice agreement shall include:
(1) The identification of the parties to the
			 agreement, including the name(s) or category of the pharmacist(s), including
			 registered pharmacist-intern(s) under the supervision of a pharmacist, who are
			 authorized to perform delegated activities under the agreement and the name(s)
			 or category of the practitioner(s) who are delegating activities under the
			 agreement;
(2) The establishment of
			 the delegating practitioner's scope of practice authorized in the agreement and
			 a description of the permitted activities and decisions to be performed by the
			 pharmacist(s);
(3) The protocol,
			 formulary, or clinical guidelines that describe or limit the pharmacist's
			 authority to perform the patient care or drug therapy management services and,
			 as applicable, the drug name, class or category provided under drug therapy
			 management;
(4) A description of
			 the process to monitor compliance with the agreement and clinical outcomes of
			 patients;
(5) The effective
			 date;
(6) A provision addressing
			 termination of the agreement; and
(7) The signatures of the parties to the
			 agreement and dates of signing, unless established by a health system pharmacy
			 and therapeutics committee.
c. Parties to the collaborative pharmacy
			 practice agreement shall review and revise such agreement as appropriate, but
			 no less than every two years.
d.
			 Any collaborative pharmacy practice agreement shall be maintained by the
			 pharmacist(s) or pharmacy and be available upon request or
			 inspection.
e. Prior to engaging in
			 patient care or drug therapy management services under a collaborative pharmacy
			 practice agreement, including when the agreement is updated, each pharmacist
			 practicing under the agreement shall attest that the pharmacist has read and
			 understands the agreement. Documentation of pharmacist attestation shall be
			 maintained for at least two years from the attestation date and be available
			 upon request or inspection.